These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 19132793

  • 1. Rheumatoid atlantoaxial subluxation can be prevented by intensive use of traditional disease modifying antirheumatic drugs.
    Kauppi MJ, Neva MH, Laiho K, Kautiainen H, Luukkainen R, Karjalainen A, Hannonen PJ, Leirisalo-Repo M, Korpela M, Ilva K, Möttönen T, FIN-RACo Trial Group.
    J Rheumatol; 2009 Feb; 36(2):273-8. PubMed ID: 19132793
    [Abstract] [Full Text] [Related]

  • 2. Combination drug therapy retards the development of rheumatoid atlantoaxial subluxations.
    Neva MH, Kauppi MJ, Kautiainen H, Luukkainen R, Hannonen P, Leirisalo-Repo M, Nissilä M, Möttönen T, FIN-RACo Trail Group.
    Arthritis Rheum; 2000 Nov; 43(11):2397-401. PubMed ID: 11083260
    [Abstract] [Full Text] [Related]

  • 3. Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: five-year experience from the FIN-RACo study.
    Korpela M, Laasonen L, Hannonen P, Kautiainen H, Leirisalo-Repo M, Hakala M, Paimela L, Blåfield H, Puolakka K, Möttönen T, FIN-RACo Trial Group.
    Arthritis Rheum; 2004 Jul; 50(7):2072-81. PubMed ID: 15248204
    [Abstract] [Full Text] [Related]

  • 4. The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial.
    Rantalaiho V, Korpela M, Hannonen P, Kautiainen H, Järvenpää S, Leirisalo-Repo M, Hakala M, Puolakka K, Julkunen H, Luosujärvi R, Möttönen T, FIN-RACo Trial Group.
    Arthritis Rheum; 2009 May; 60(5):1222-31. PubMed ID: 19404945
    [Abstract] [Full Text] [Related]

  • 5. Sustained remission and reduced radiographic progression with combination disease modifying antirheumatic drugs in early rheumatoid arthritis.
    Mäkinen H, Kautiainen H, Hannonen P, Möttönen T, Leirisalo-Repo M, Laasonen L, Korpela M, Blåfield H, Hakola M, Sokka T.
    J Rheumatol; 2007 Feb; 34(2):316-21. PubMed ID: 17183623
    [Abstract] [Full Text] [Related]

  • 6. Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis.
    Möttönen T, Hannonen P, Korpela M, Nissilä M, Kautiainen H, Ilonen J, Laasonen L, Kaipiainen-Seppänen O, Franzen P, Helve T, Koski J, Gripenberg-Gahmberg M, Myllykangas-Luosujärvi R, Leirisalo-Repo M, FIN-RACo Trial Group. FINnish Rheumatoid Arthritis Combination therapy.
    Arthritis Rheum; 2002 Apr; 46(4):894-8. PubMed ID: 11953964
    [Abstract] [Full Text] [Related]

  • 7. Serum soluble interleukin-2 receptor predicts early remission in patients with recent-onset rheumatoid arthritis treated with a single disease-modifying antirheumatic drug.
    Kuuliala A, Leirisalo-Repo M, Möttönen T, Hannonen P, Nissilä M, Kautiainen H, Korpela M, Julkunen H, Hakola M, Repo H, FIN-RACo Trial Group.
    Clin Exp Rheumatol; 2005 Apr; 23(2):243-6. PubMed ID: 15895898
    [Abstract] [Full Text] [Related]

  • 8. Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial.
    Svensson B, Boonen A, Albertsson K, van der Heijde D, Keller C, Hafström I.
    Arthritis Rheum; 2005 Nov; 52(11):3360-70. PubMed ID: 16255010
    [Abstract] [Full Text] [Related]

  • 9. Renal safety of initial combination versus single DMARD therapy in patients with early rheumatoid arthritis: an 11-year experience from the FIN-RACo Trial.
    Karstila KL, Rantalaiho VM, Mustonen JT, Möttönen TT, Hannonen PJ, Leirisalo-Repo M, Kaipiainen-Seppänen OA, Karjalainen AH, Korpela MM, FIN-RACo Trial Group.
    Clin Exp Rheumatol; 2010 Nov; 28(1):73-8. PubMed ID: 20346242
    [Abstract] [Full Text] [Related]

  • 10. Cervical Spine Involvement among Patients with Rheumatoid Arthritis Treated Actively with Treat-to-target Strategy: 10-year Results of the NEO-RACo Study.
    Sandström T, Rantalaiho V, Yli-Kerttula T, Kautiainen H, Malmi T, Karjalainen A, Uusitalo T, Julkunen H, Kaipiainen-Seppänen O, Paimela L, Puolakka K, Uutela T, Möttönen T, Hannonen P, Leirisalo-Repo M, Laasonen L, Kauppi M, NEO-RACo Study Group.
    J Rheumatol; 2020 Aug 01; 47(8):1160-1164. PubMed ID: 31732558
    [Abstract] [Full Text] [Related]

  • 11. Early Targeted Combination Treatment With Conventional Synthetic Disease-Modifying Antirheumatic Drugs and Long-Term Outcomes in Rheumatoid Arthritis: Ten-Year Follow-Up Results of a Randomized Clinical Trial.
    Rantalaiho V, Sandström T, Koski J, Hannonen P, Möttönen T, Kaipiainen-Seppänen O, Yli-Kerttula T, Kauppi MJ, Uutela T, Malmi T, Julkunen H, Laasonen L, Kautiainen H, Leirisalo-Repo M, NEO-RACo Study Group.
    Arthritis Care Res (Hoboken); 2019 Nov 01; 71(11):1450-1458. PubMed ID: 30295425
    [Abstract] [Full Text] [Related]

  • 12. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial.
    Puolakka K, Kautiainen H, Möttönen T, Hannonen P, Korpela M, Julkunen H, Luukkainen R, Vuori K, Paimela L, Blåfield H, Hakala M, Leirisalo-Repo M.
    Arthritis Rheum; 2004 Jan 01; 50(1):55-62. PubMed ID: 14730599
    [Abstract] [Full Text] [Related]

  • 13. A 10 year prospective followup of patients with rheumatoid arthritis 1986-96.
    Gordon P, West J, Jones H, Gibson T.
    J Rheumatol; 2001 Nov 01; 28(11):2409-15. PubMed ID: 11708411
    [Abstract] [Full Text] [Related]

  • 14. Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: a multicenter, double-blind, placebo-controlled trial.
    Wassenberg S, Rau R, Steinfeld P, Zeidler H.
    Arthritis Rheum; 2005 Nov 01; 52(11):3371-80. PubMed ID: 16255011
    [Abstract] [Full Text] [Related]

  • 15. Failure in longterm treatment is rare in actively treated patients with rheumatoid arthritis, but may be predicted by high health assessment score at baseline and by residual disease activity at 3 and 6 months: the 5-year followup results of the randomized clinical NEO-RACo trial.
    Rantalaiho V, Kautiainen H, Järvenpää S, Korpela M, Malmi T, Hannonen P, Kaipiainen-Seppänen O, Yli-Kerttula T, Möttönen T, Mustila A, Karjalainen A, Paimela L, Uutela T, Leirisalo-Repo M, NEO-RACo Study Group.
    J Rheumatol; 2014 Dec 01; 41(12):2379-85. PubMed ID: 25274892
    [Abstract] [Full Text] [Related]

  • 16. Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?
    Ciubotariu E, Gabay C, Finckh A, Physicians of the Swiss Clinical Quality Management Program for Rheumatoid Arthritis.
    J Rheumatol; 2014 Aug 01; 41(8):1576-82. PubMed ID: 25028383
    [Abstract] [Full Text] [Related]

  • 17. Stability of the upper neck during isometric neck exercises in rheumatoid arthritis patients with atlantoaxial disorders.
    Hakkinen A, Makinen H, Ylinen J, Hannonen P, Sokka T, Neva M, Kautiainen H, Kauppi M.
    Scand J Rheumatol; 2008 Aug 01; 37(5):343-7. PubMed ID: 18609259
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of occipitocervical subluxation in rheumatoid arthritis patients, using coronal-view reconstructive computed tomography.
    Nagayoshi R, Ijiri K, Takenouchi T, Taketomi E, Sakakima H, Komiya S.
    Spine (Phila Pa 1976); 2009 Nov 15; 34(24):E879-81. PubMed ID: 19910756
    [Abstract] [Full Text] [Related]

  • 19. Predictors for the progression of cervical lesion in rheumatoid arthritis under the treatment of biological agents.
    Kaito T, Ohshima S, Fujiwara H, Makino T, Yonenobu K.
    Spine (Phila Pa 1976); 2013 Dec 15; 38(26):2258-63. PubMed ID: 24150439
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.